IBDEI10O ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16535,2)
;;=^5001108
;;^UTILITY(U,$J,358.3,16536,0)
;;=C22.0^^61^775^104
;;^UTILITY(U,$J,358.3,16536,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16536,1,3,0)
;;=3^Liver Cell Carcinoma
;;^UTILITY(U,$J,358.3,16536,1,4,0)
;;=4^C22.0
;;^UTILITY(U,$J,358.3,16536,2)
;;=^5000933
;;^UTILITY(U,$J,358.3,16537,0)
;;=D05.02^^61^775^105
;;^UTILITY(U,$J,358.3,16537,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16537,1,3,0)
;;=3^Lobular Carcinoma in Situ,Left Breast
;;^UTILITY(U,$J,358.3,16537,1,4,0)
;;=4^D05.02
;;^UTILITY(U,$J,358.3,16537,2)
;;=^5001928
;;^UTILITY(U,$J,358.3,16538,0)
;;=D05.01^^61^775^106
;;^UTILITY(U,$J,358.3,16538,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16538,1,3,0)
;;=3^Lobular Carcinoma in Situ,Right Breast
;;^UTILITY(U,$J,358.3,16538,1,4,0)
;;=4^D05.01
;;^UTILITY(U,$J,358.3,16538,2)
;;=^5001927
;;^UTILITY(U,$J,358.3,16539,0)
;;=D05.00^^61^775^107
;;^UTILITY(U,$J,358.3,16539,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16539,1,3,0)
;;=3^Lobular Carcinoma in Situ,Unspec Breast
;;^UTILITY(U,$J,358.3,16539,1,4,0)
;;=4^D05.00
;;^UTILITY(U,$J,358.3,16539,2)
;;=^5001926
;;^UTILITY(U,$J,358.3,16540,0)
;;=R59.0^^61^775^66
;;^UTILITY(U,$J,358.3,16540,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16540,1,3,0)
;;=3^Enlarged Lymph Nodes,Localized
;;^UTILITY(U,$J,358.3,16540,1,4,0)
;;=4^R59.0
;;^UTILITY(U,$J,358.3,16540,2)
;;=^5019529
;;^UTILITY(U,$J,358.3,16541,0)
;;=C83.59^^61^775^108
;;^UTILITY(U,$J,358.3,16541,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16541,1,3,0)
;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
;;^UTILITY(U,$J,358.3,16541,1,4,0)
;;=4^C83.59
;;^UTILITY(U,$J,358.3,16541,2)
;;=^5001590
;;^UTILITY(U,$J,358.3,16542,0)
;;=C83.50^^61^775^109
;;^UTILITY(U,$J,358.3,16542,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16542,1,3,0)
;;=3^Lymphoblastic Lymphoma,Unspec Site
;;^UTILITY(U,$J,358.3,16542,1,4,0)
;;=4^C83.50
;;^UTILITY(U,$J,358.3,16542,2)
;;=^5001581
;;^UTILITY(U,$J,358.3,16543,0)
;;=C43.9^^61^775^112
;;^UTILITY(U,$J,358.3,16543,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16543,1,3,0)
;;=3^Malig Melanoma of Skin,Unspec Site
;;^UTILITY(U,$J,358.3,16543,1,4,0)
;;=4^C43.9
;;^UTILITY(U,$J,358.3,16543,2)
;;=^5001015
;;^UTILITY(U,$J,358.3,16544,0)
;;=C31.9^^61^775^113
;;^UTILITY(U,$J,358.3,16544,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16544,1,3,0)
;;=3^Malig Neop Accessory Sinus,Unspec
;;^UTILITY(U,$J,358.3,16544,1,4,0)
;;=4^C31.9
;;^UTILITY(U,$J,358.3,16544,2)
;;=^5000953
;;^UTILITY(U,$J,358.3,16545,0)
;;=C24.1^^61^775^115
;;^UTILITY(U,$J,358.3,16545,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16545,1,3,0)
;;=3^Malig Neop Ampulla of Vater
;;^UTILITY(U,$J,358.3,16545,1,4,0)
;;=4^C24.1
;;^UTILITY(U,$J,358.3,16545,2)
;;=^267100
;;^UTILITY(U,$J,358.3,16546,0)
;;=C21.0^^61^775^116
;;^UTILITY(U,$J,358.3,16546,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16546,1,3,0)
;;=3^Malig Neop Anus,Unspec
;;^UTILITY(U,$J,358.3,16546,1,4,0)
;;=4^C21.0
;;^UTILITY(U,$J,358.3,16546,2)
;;=^5000930
;;^UTILITY(U,$J,358.3,16547,0)
;;=C67.9^^61^775^119
;;^UTILITY(U,$J,358.3,16547,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16547,1,3,0)
;;=3^Malig Neop Bladder,Unspec
;;^UTILITY(U,$J,358.3,16547,1,4,0)
;;=4^C67.9
;;^UTILITY(U,$J,358.3,16547,2)
;;=^5001263
;;^UTILITY(U,$J,358.3,16548,0)
;;=C71.9^^61^775^123
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10O 3781 printed Sep 23, 2025@19:35:26 Page 2
IBDEI10O ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16535,2)
+2 ;;=^5001108
+3 ;;^UTILITY(U,$J,358.3,16536,0)
+4 ;;=C22.0^^61^775^104
+5 ;;^UTILITY(U,$J,358.3,16536,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,16536,1,3,0)
+8 ;;=3^Liver Cell Carcinoma
+9 ;;^UTILITY(U,$J,358.3,16536,1,4,0)
+10 ;;=4^C22.0
+11 ;;^UTILITY(U,$J,358.3,16536,2)
+12 ;;=^5000933
+13 ;;^UTILITY(U,$J,358.3,16537,0)
+14 ;;=D05.02^^61^775^105
+15 ;;^UTILITY(U,$J,358.3,16537,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,16537,1,3,0)
+18 ;;=3^Lobular Carcinoma in Situ,Left Breast
+19 ;;^UTILITY(U,$J,358.3,16537,1,4,0)
+20 ;;=4^D05.02
+21 ;;^UTILITY(U,$J,358.3,16537,2)
+22 ;;=^5001928
+23 ;;^UTILITY(U,$J,358.3,16538,0)
+24 ;;=D05.01^^61^775^106
+25 ;;^UTILITY(U,$J,358.3,16538,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,16538,1,3,0)
+28 ;;=3^Lobular Carcinoma in Situ,Right Breast
+29 ;;^UTILITY(U,$J,358.3,16538,1,4,0)
+30 ;;=4^D05.01
+31 ;;^UTILITY(U,$J,358.3,16538,2)
+32 ;;=^5001927
+33 ;;^UTILITY(U,$J,358.3,16539,0)
+34 ;;=D05.00^^61^775^107
+35 ;;^UTILITY(U,$J,358.3,16539,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,16539,1,3,0)
+38 ;;=3^Lobular Carcinoma in Situ,Unspec Breast
+39 ;;^UTILITY(U,$J,358.3,16539,1,4,0)
+40 ;;=4^D05.00
+41 ;;^UTILITY(U,$J,358.3,16539,2)
+42 ;;=^5001926
+43 ;;^UTILITY(U,$J,358.3,16540,0)
+44 ;;=R59.0^^61^775^66
+45 ;;^UTILITY(U,$J,358.3,16540,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,16540,1,3,0)
+48 ;;=3^Enlarged Lymph Nodes,Localized
+49 ;;^UTILITY(U,$J,358.3,16540,1,4,0)
+50 ;;=4^R59.0
+51 ;;^UTILITY(U,$J,358.3,16540,2)
+52 ;;=^5019529
+53 ;;^UTILITY(U,$J,358.3,16541,0)
+54 ;;=C83.59^^61^775^108
+55 ;;^UTILITY(U,$J,358.3,16541,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,16541,1,3,0)
+58 ;;=3^Lymphoblastic Lymphoma,Extranodal/Solid Organ Sites
+59 ;;^UTILITY(U,$J,358.3,16541,1,4,0)
+60 ;;=4^C83.59
+61 ;;^UTILITY(U,$J,358.3,16541,2)
+62 ;;=^5001590
+63 ;;^UTILITY(U,$J,358.3,16542,0)
+64 ;;=C83.50^^61^775^109
+65 ;;^UTILITY(U,$J,358.3,16542,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,16542,1,3,0)
+68 ;;=3^Lymphoblastic Lymphoma,Unspec Site
+69 ;;^UTILITY(U,$J,358.3,16542,1,4,0)
+70 ;;=4^C83.50
+71 ;;^UTILITY(U,$J,358.3,16542,2)
+72 ;;=^5001581
+73 ;;^UTILITY(U,$J,358.3,16543,0)
+74 ;;=C43.9^^61^775^112
+75 ;;^UTILITY(U,$J,358.3,16543,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,16543,1,3,0)
+78 ;;=3^Malig Melanoma of Skin,Unspec Site
+79 ;;^UTILITY(U,$J,358.3,16543,1,4,0)
+80 ;;=4^C43.9
+81 ;;^UTILITY(U,$J,358.3,16543,2)
+82 ;;=^5001015
+83 ;;^UTILITY(U,$J,358.3,16544,0)
+84 ;;=C31.9^^61^775^113
+85 ;;^UTILITY(U,$J,358.3,16544,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,16544,1,3,0)
+88 ;;=3^Malig Neop Accessory Sinus,Unspec
+89 ;;^UTILITY(U,$J,358.3,16544,1,4,0)
+90 ;;=4^C31.9
+91 ;;^UTILITY(U,$J,358.3,16544,2)
+92 ;;=^5000953
+93 ;;^UTILITY(U,$J,358.3,16545,0)
+94 ;;=C24.1^^61^775^115
+95 ;;^UTILITY(U,$J,358.3,16545,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,16545,1,3,0)
+98 ;;=3^Malig Neop Ampulla of Vater
+99 ;;^UTILITY(U,$J,358.3,16545,1,4,0)
+100 ;;=4^C24.1
+101 ;;^UTILITY(U,$J,358.3,16545,2)
+102 ;;=^267100
+103 ;;^UTILITY(U,$J,358.3,16546,0)
+104 ;;=C21.0^^61^775^116
+105 ;;^UTILITY(U,$J,358.3,16546,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,16546,1,3,0)
+108 ;;=3^Malig Neop Anus,Unspec
+109 ;;^UTILITY(U,$J,358.3,16546,1,4,0)
+110 ;;=4^C21.0
+111 ;;^UTILITY(U,$J,358.3,16546,2)
+112 ;;=^5000930
+113 ;;^UTILITY(U,$J,358.3,16547,0)
+114 ;;=C67.9^^61^775^119
+115 ;;^UTILITY(U,$J,358.3,16547,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,16547,1,3,0)
+118 ;;=3^Malig Neop Bladder,Unspec
+119 ;;^UTILITY(U,$J,358.3,16547,1,4,0)
+120 ;;=4^C67.9
+121 ;;^UTILITY(U,$J,358.3,16547,2)
+122 ;;=^5001263
+123 ;;^UTILITY(U,$J,358.3,16548,0)
+124 ;;=C71.9^^61^775^123
